Fundlogic Alternatives Plc-Scibeta Hfe Pacific Ex-Jap Equity 6f Ew Ucits Etf
PHEF.L
London Stock Exchange- -
EUR
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- FundLogic Alternatives Plc-SciBeta HFE Pacific Ex-Jap Equity 6F EW UCITS ETF (PHEF.L) is an exchange-traded fund incorporated in Ireland that seeks medium- to long-term capital appreciation by tracking the Scientific Beta Developed Asia-Pacific ex-Japan HFI Multi-Beta Multi-Strategy Six-Factor Equal Weight Market Beta Adjusted index. The ETF employs a synthetic replication strategy via an unfunded swap, with an accumulating distribution policy that reinvests dividends, a total expense ratio of 0.30% per annum, and exposure to equities in the Pacific region excluding Japan, selected and weighted based on six factors including size, value, momentum, low volatility, high profitability, and low investment, using strategies such as efficient maximum Sharpe ratio, efficient minimum volatility, maximum deconcentration, maximum decorrelation, and diversified risk parity. It targets institutional and retail investors seeking multi-factor equity strategies in the Asia-Pacific ex-Japan market, operates without currency hedging, and lists primarily on the London Stock Exchange in euros. As a sub-fund of FundLogic Alternatives Plc, now operating under Morgan Stanley's alternatives and systematic investment solutions platform launched in 2006 and headquartered in Dublin, Ireland, the ETF benefits from the promoter's broader offerings in UCITS-compliant funds across absolute return third-party strategies and rules-based indices spanning multiple asset classes. FundLogic Alternatives Plc, registered at 70 Sir John Rogerson's Quay, Dublin 2, functions as an umbrella open-ended investment company with segregated liability between sub-funds, managed with support from administrator Northern Trust International Fund Administration Services (Ireland) Limited, custodian Northern Trust Fiduciary Services (Ireland) Limited, and auditors Ernst & Young. Launched on December 8, 2017, and approved by the Central Bank of Ireland on November 30, 2017, the ETF has maintained a low assets under management profile at approximately EUR 0 million as of recent data, reflecting its niche focus amid a competitive multi-factor ETF landscape. No major partnerships, acquisitions, funding rounds, product launches, or strategic shifts specific to this sub-fund have been reported in the last 1-2 years; it continues standard operations with periodic net asset value publications, such as NAV per share of 116.02 on September 12, 2024, and ongoing compliance under UCITS regulations. The fund remains part of Morgan Stanley's Scientific Beta suite, which includes similar ETFs targeting Europe, US, Japan, and global equities, without noted reorganizations or expansions.